Immunoglobulin M (IgM) to hepatitis C virus (HCV) core in patients with chronic hepatitis C: Correlation with histological features, HCV-serotype, and response to interferon therapy.

被引：0
|
作者：
Tran, A [1 ]
Yang, G [1 ]
Dreyfus, G [1 ]
Rouquie, P [1 ]
Durant, J [1 ]
Rampal, A [1 ]
Rampal, P [1 ]
Benzaken, S [1 ]
机构：
[1] HOP ARCHET, LIVER UNIT, NICE, FRANCE
来源：
GASTROENTEROLOGY | 1997年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1403 / A1403
页数：1
相关论文
共 50 条
  • [21] Antidepressant prescribing in Medicaid patients with hepatitis-C virus (HCV) before and after HCV diagnosis and prior to the initiation of interferon therapy.
    Markowitz, JS
    Gutterman, EM
    HEPATOLOGY, 2003, 38 (04) : 628A - 628A
  • [22] Distribution of hepatitis C virus (HCV) in Spanish patients with chronic hepatitis C.
    Garcia-Valriberas, R
    Soto-Pedre, E
    Fernandez-Bermejo, M
    Bohorque, MJ
    Lo Iacono, O
    Garcia-Buey, M
    Moreno-Otero, R
    GASTROENTEROLOGY, 1999, 116 (04) : A1214 - A1214
  • [23] Prevalence of hepatitis C virus (HCV) infection in spouses of patients with chronic hepatitis "C"
    Memon, Sadik
    Momin, Abu Bakar
    Memon, Aaqil
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A25 - A25
  • [24] Hepatitis C virus (HCV) core antigen kinetics during treatment of chronic hepatitis C with interferon alpha and/or ribavirin.
    Dahari, H
    Hezode, C
    Bouvier-Alias, M
    Dhumeaux, D
    Neumann, AU
    Pawlotsky, JM
    HEPATOLOGY, 2001, 34 (04) : 217A - 217A
  • [25] Significance of IgM anti-HCV core level in chronic hepatitis C
    Papatheodoridis, GV
    Delladetsima, JK
    Katsoulidou, A
    Sypsa, V
    Albrecht, M
    Michel, G
    Hatzakis, A
    Tassopoulos, NC
    JOURNAL OF HEPATOLOGY, 1997, 27 (01) : 36 - 41
  • [26] Early determination of hepatitis C virus (HCV) RNA accurately predicts non response in patients deceiving induction interferon therapy.
    Rossini, A
    Artini, M
    Cesalpino, FA
    Corbellini, C
    Almerighi, C
    Cesalpino, FA
    Massari, M
    Levrero, M
    Radaeli, E
    Cariani, E
    HEPATOLOGY, 2000, 32 (04) : 359A - 359A
  • [27] Levels of antibodies to HCV structural antigens correlate with serum HCV RNA levels in chronic hepatitis C patients undergoing interferon therapy.
    Niven, PC
    Madjor, D
    Samson, A
    Lee, SR
    Green, GA
    Gwo, JR
    Fong, TL
    HEPATOLOGY, 1999, 30 (04) : 609A - 609A
  • [28] SERUM HEPATITIS-C VIRUS (HCV)-RNA AND RESPONSE TO ALPHA-INTERFERON IN ANTI-HCV POSITIVE CHRONIC HEPATITIS
    MAGRIN, S
    CRAXI, A
    FABIANO, C
    FIORENTINO, G
    MARINO, L
    ALMASIO, P
    PINZELLO, GB
    PALAZZO, U
    VITALE, M
    MAGGIO, A
    BUCCA, G
    GIANGUZZA, F
    SHYAMALA, V
    HAN, JH
    PAGLIARO, L
    JOURNAL OF MEDICAL VIROLOGY, 1992, 38 (03) : 200 - 206
  • [29] Retreatment of Chronic Hepatitis C Virus (HCV): Predictors of Response
    Abrol, Robinder
    Berger, Scott
    Bahnshal, Sarah
    Ortiz, Herman
    Egwim, Chukwuma
    Ankoma-Sey, Victor
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1495 - S1495
  • [30] Occult hepatitis B virus (HBV) infection in patients with hepatitis C virus (HCV) chronic hepatitis is not due to HBV genomic mutations and is related with severity of liver disease and lack of response to interferon therapy.
    Cacciola, I
    Pollicino, T
    Squadrito, G
    Cerenzia, G
    Longo, G
    Raimondo, G
    HEPATOLOGY, 1998, 28 (04) : 723A - 723A
12345